793
Participants
Start Date
May 2, 2019
Primary Completion Date
March 14, 2022
Study Completion Date
January 27, 2024
Pembrolizumab
IV infusion
Olaparib
Oral tablets
Abiraterone acetate
Oral tablets
Prednisone
Oral tablets
Enzalutamide
Oral tablets or oral capsules
Prednisolone
Oral tablets
Taichung Veterans General Hospital ( Site 0133), Taichung
National Cheng Kung University Hospital ( Site 0134), Tainen
Auckland City Hospital ( Site 0193), Auckland
Medizinische Universitaet Wien ( Site 0375), Vienna
St. Vincent's Hospital ( Site 0158), Darlinghurst
Macquarie University ( Site 0151), Macquarie University
Calvary Mater Newcastle ( Site 0148), Waratah
Port Macquarie Base Hospital ( Site 0153), Port Macquarie
Southern Medical Day Care Centre ( Site 0160), Wollongong
Peter MacCallum Cancer Centre ( Site 0152), Melbourne
Box Hill Hospital ( Site 0146), Box Hill
Ordensklinikum Linz GmbH Elisabethinen ( Site 0373), Linz
Royal Brisbane and Women s Hospital ( Site 0155), Herston
John Flynn Hospital & Medical Centre ( Site 0164), Tugun
SCRI-CCCIT GesmbH ( Site 0371), Salzburg
Fiona Stanley Hospital ( Site 0162), Murdoch
Medizinische Universitat Graz ( Site 0374), Graz
Hospital San Pedro de Alcantara ( Site 0326), Cáceres
National Taiwan University Hospital ( Site 0131), Taipei
Charité Universitaetsmedizin Berlin - Campus Mitte ( Site 0301), Berlin
National Cancer Center ( Site 0176), Goyang-si
Taipei Veterans General Hospital ( Site 0135), Taipei
Institut Paoli Calmettes ( Site 0419), Marseille
Associated Medical Professionals of NY ( Site 0060), Syracuse
Hospital Josep Trueta ( Site 0321), Girona
Sibley Memorial Hospital ( Site 0096), Washington D.C.
Istituto Clinico Humanitas Research Hospital ( Site 0452), Rozzano
Chesapeake Urology Research Associates ( Site 0076), Towson
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins ( Site 0005), Baltimore
Virginia Cancer Institute ( Site 0052), Richmond
Blue Ridge Cancer Care ( Site 0086), Roanoke
CHU Jean Minjoz ( Site 0423), Besançon
Duke Cancer Center Cary ( Site 0010), Cary
Hospital Quiron Madrid ( Site 0325), Pozuelo de Alarcón
Hospital Universitario Virgen de la Victoria ( Site 0337), Málaga
CHU de Brest -Site Hopital Morvan ( Site 0441), Brest
Carolina Urologic Research Center ( Site 0070), Myrtle Beach
Georgia Cancer Center at Augusta University ( Site 0026), Augusta
Institut Claudius Regaud IUCT Oncopole ( Site 0418), Toulouse
Institut Bergonie ( Site 0421), Bordeaux
Institut Regional du Cancer de Montpellier - ICM ( Site 0443), Montpellier
Presidio Ospedaliero Santa Chiara ( Site 0451), Trento
Policlinico S.Orsola-Malpighi ( Site 0453), Bologna
Universitaetsklinikum Duesseldorf ( Site 0306), Düsseldorf
China Medical University Hospital ( Site 0132), Taichung
University Hospitals of Cleveland Seidman Cancer Center ( Site 0036), Cleveland
Gabrail Cancer Center-Research ( Site 0097), Canton
Institut De Cancerologie De L Ouest ( Site 0448), Saint-Herblain
Centre Hospitalier Regional du Orleans ( Site 0430), Orléans
The Urology Group- Cincinnati ( Site 0094), Cincinnati
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori ( Site 0462), Meldola
Barbara Ann Karmanos Cancer Institute ( Site 0077), Detroit
Henry Ford Health System ( Site 0039), Detroit
Medical Oncology Ospedale San Donato ( Site 0461), Arezzo
Froedtert and Medical College of Wisconsin ( Site 0045), Milwaukee
Centre D Oncologie de Gentilly ( Site 0432), Nancy
Krankenhaus der Barmherzigen Brueder Trier ( Site 0310), Trier
Chonnam National University Hwasun Hospital ( Site 0174), Hwasun Gun
St. Vincent Frontier Cancer Center ( Site 0016), Billings
Quincy Medical Group ( Site 0021), Quincy
Centre Jean Perrin ( Site 0434), Clermont-Ferrand
Clinique Sainte Anne ( Site 0431), Strasbourg
Nebraska Cancer Specialists ( Site 0034), Omaha
Universitaetsklinikum in Mannheim ( Site 0314), Mannheim
C.H.U. Lyon Sud ( Site 0436), Pierre-Bénite
Centre Leon Berard ( Site 0422), Lyon
Tulane Cancer Center ( Site 0066), New Orleans
Universitaetsklinik fuer Urologie ( Site 0307), Tübingen
Studienpraxis Urologie ( Site 0309), Nürtingen
Institut Mutualiste Montsouris ( Site 0446), Paris
Universitaetsklinikum Freiburg - Medizinische Klinik ( Site 0304), Freiburg im Breisgau
CHU Amiens Picardie Site Sud Amiens ( Site 0438), Amiens
Klinikum Rechts der Isar ( Site 0300), Munich
Institut Sainte Catherine ( Site 0447), Avignon
Huntsman Cancer Institute ( Site 0002), Salt Lake City
University of New Mexico Cancer Center ( Site 0048), Albuquerque
Memorial Medical Center ( Site 0095), Las Cruces
Comprehensive Cancer Centers of Nevada ( Site 0092), Las Vegas
UCLA Hematology/Oncology - Santa Monica ( Site 0081), Los Angeles
Universitaetsklinik der Paracelsus Medizinischen Privatuniversitaet ( Site 0318), Nuremberg
Universitaetsklinikum Erlangen ( Site 0303), Erlangen
Hopital Foch ( Site 0428), Suresnes
St. Joseph Heritage Healthcare ( Site 0069), Fullerton
Institut Gustave Roussy ( Site 0416), Villejuif
Azienda Ospedaliera Cannizzaro ( Site 0458), Catania
Seattle Cancer Care Alliance ( Site 0079), Seattle
Russian Scientific Center of Roentgenoradiology ( Site 0559), Moscow
Central Clinical Hospital with Polyclinic ( Site 0562), Moscow
SBHI Leningrad Regional Oncology Dispensary ( Site 0588), Saint Petersburg
Clinical Research Center of specialized types medical care-Oncology ( Site 0570), Saint Petersburg
Russian Scientific Center of Radiology and Surgical Technologies ( Site 0567), Saint Petersburg
SBHI Samara Regional Clinical Oncology Dispensary ( Site 0576), Samara
Chelyabinsk Regional Clinical Oncological Dispensary ( Site 0565), Chelyabinsk
Tomsk National Scientific Medical Center of Russian Academy of Science ( Site 0579), Tomsk
Omsk Clinical Oncology Dispensary ( Site 0568), Omsk
Krasnoyarsk Regional Clinical Oncological Dispensary ( Site 0585), Krasnoyarsk
Ha Emek Medical Center ( Site 0548), Afula
Rambam Medical Center ( Site 0543), Haifa
Meir Medical Center ( Site 0544), Kfar Saba
Centro Investigación del Cáncer James Lind ( Site 1041), Temuco
Rey y Oreilly Limitada ( Site 1048), Temuco
Rabin Medical Center ( Site 0545), Petah Tikva
Chaim Sheba Medical Center ( Site 0541), Ramat Gan
Sourasky Medical Center ( Site 0542), Tel Aviv
Assaf Harofe ( Site 0547), Be’er Ya‘aqov
Fundacion Arturo Lopez Perez ( Site 1049), Santiago
Pontificia Universidad Catolica de Chile ( Site 1047), Santiago
Soroka Medical Center ( Site 0549), Beersheba
Bradford Hill Centro de Investigaciones Clinicas ( Site 1044), Santiago
Hadassah Ein Kerem Medical Center ( Site 0546), Jerusalem
Beth Israel Deaconess Medical Ctr. ( Site 0093), Boston
Dana Farber Cancer Institute ( Site 0033), Boston
UMass Memorial Medical Center ( Site 0053), Worcester
Centro de Oncologia e Investigacion Buenos Aires COIBA ( Site 1013), Berazategui
Centro de Diagnostico Urologico ( Site 1008), Buenos Aires
Hospital Britanico de Buenos Aires ( Site 1006), Buenos Aires
Sanatorio Parque ( Site 1002), Rosario
Instituto de Investigaciones Metabolicas ( Site 1011), Buenos Aires
Hospital Aleman ( Site 1004), Buenos Aires
Instituto Medico Alexander Fleming ( Site 1010), Buenos Aires
CEMAIC ( Site 1014), Córdoba
Hospital de Caridade de Ijui ( Site 1038), Ijuí
Uniao Brasileira de Educacao e Assistencia Hospital Sao Lucas da Pucrs ( Site 1021), Porto Alegre
Centro de Novos Tratamentos Itajai - Clinica de Neoplasias Litoral ( Site 1035), Itajaí
Hospital de Base de Sao Jose de Rio Preto ( Site 1022), São José do Rio Preto
IBCC - Instituto Brasileiro de Controle do Câncer ( Site 1040), São Paulo
A.C. Camargo Cancer Center ( Site 1026), São Paulo
Cross Cancer Institute ( Site 0110), Edmonton
BC Cancer-Kelowna - Sindi Ahluwalia Hawkins Centre ( Site 0113), Kelowna
BC Cancer-Vancouver Center ( Site 0112), Vancouver
Nova Scotia Health Authority QEII-HSC ( Site 0114), Halifax
William Osler Health System (Brampton Civic Hospital) ( Site 0121), Brampton
Hamilton Health Sciences-Juravinski Cancer Centre ( Site 0116), Hamilton
Princess Margaret Cancer Centre ( Site 0107), Toronto
CHUQ-Univ Laval-Hotel Dieu de Quebec ( Site 0103), Québec
CIUSSS du Bas Saint Laurent - Hopital Regional de Rimouski ( Site 0102), Rimouski
CIUSSS de l Estrie - CHUS - Centre Hosp. Univ. Sherbrooke ( Site 0105), Sherbrooke
C.H. de Saint Quentin ( Site 0481), Saint-Quentin
Universitaetsklinikum Jena ( Site 0305), Jena
Tallaght University Hospital ( Site 0730), Dublin
Mid Western Cancer Centre ( Site 0728), Limerick
Azienda Ospedaliera San Camillo Forlanini ( Site 0455), Roma
Fondazione Policlinico Universitario A. Gemelli ( Site 0463), Roma
Azienda Ospedaliera Santa Maria Terni ( Site 0456), Terni
Fujita Health University Hospital ( Site 0724), Toyoake
National Cancer Center Hospital East ( Site 0702), Kashiwa
Toho University Sakura Medical Center ( Site 0703), Sakura
National Hospital Organization Shikoku Cancer Center ( Site 0716), Matsuyama
Kobe City Medical Center General Hospital ( Site 0726), Kobe
Kanazawa University Hospital ( Site 0701), Kanazawa
Kitasato University Hospital ( Site 0705), Sagamihara
Yokohama City University Medical Center ( Site 0706), Yokohama
Nara Medical University Hospital ( Site 0715), Kashihara
Kindai University Hospital ( Site 0714), Sayama
Osaka University Hospital ( Site 0713), Suita
Saitama Medical University International Medical Center ( Site 0708), Hidaka
Dokkyo Medical University Saitama Medical Center ( Site 0707), Koshigaya
Fuji City General Hospital ( Site 0725), Fuji
Hamamatsu University Hospital ( Site 0720), Hamamatsu
Yamaguchi University Hospital ( Site 0717), Ube
Chiba Cancer Center ( Site 0704), Chiba
Kyushu University Hospital ( Site 0718), Fukuoka
University of Miyazaki Hospital ( Site 0721), Miyazaki
Nagano Municipal Hospital ( Site 0723), Nagano
Nagasaki University Hospital ( Site 0719), Nagasaki
Osaka International Cancer Institute ( Site 0722), Osaka
Toranomon Hospital ( Site 0711), Tokyo
Nippon Medical School Hospital ( Site 0709), Tokyo
Keio University Hospital ( Site 0710), Tokyo
Radboud University Medical Center ( Site 0470), Nijmegen
Antoni van Leeuwenhoek Ziekenhuis ( Site 0480), Amsterdam
Vrije Universiteit Medisch Centrum ( Site 0479), Amsterdam
Spaarne Ziekenhuis ( Site 0473), Hoofddorp
Ziekenhuisgroep Twente ( Site 0469), Hengelo
Medisch Centrum Leeuwarden ( Site 0477), Leeuwarden
Haaglanden MC - locatie Antoniushove ( Site 0471), Leidschendam
Erasmus MC ( Site 0475), Rotterdam
Franciscus Gasthuis en Vlietland ( Site 0489), Schiedam
Asan Medical Center ( Site 0171), Songpagu
Severance Hospital Yonsei University Health System ( Site 0173), Seoul
Samsung Medical Center ( Site 0172), Seoul
Instituto Catalan de Oncologia - ICO ( Site 0330), L'Hospitalet de Llobregat
Hospital Parc Tauli ( Site 0335), Sabadell
Hospital del Mar ( Site 0333), Barcelona
Hospital General Universitari Vall d Hebron ( Site 0334), Barcelona
Hospital Clinic ( Site 0323), Barcelona
University Hospitals Bristol NHS Foundation Trust ( Site 0530), Bristol
Cambridge University Hospitals NHS Trust ( Site 0540), Cambridge
Torbay Hospital ( Site 0532), Torquay
Royal Marsden Hospital ( Site 0526), Sutton
Musgrove Park Hospital ( Site 0537), Taunton
University of North Midlands NHS Foundation Trust ( Site 0527), Stoke-on-Trent
Mount Vernon Cancer Centre ( Site 0536), Northwood
Merck Sharp & Dohme LLC
INDUSTRY